TFF Pharmaceuticals CEO Harlan Weisman's 2023 pay jumps 4,848% to $2.1M
TFF Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: April 22, 2024
TFF Pharmaceuticals reported fiscal year 2023 executive compensation information on April 22, 2024.
In 2023, three executives at TFF Pharmaceuticals received on average a compensation package of $1.1M, a 262% increase compared to previous year.
Average pay of disclosed executives at TFF Pharmaceuticals
Harlan Weisman, Chief Executive Officer, received $2.1M in total, which increased by 4,848% compared to 2022. 64% of Weisman's compensation, or $1.3M, was in option awards. Weisman also received $193K in bonus and $550K in salary.
Zamaneh Mikhak, Chief Marketing Officer, received a compensation package of $861K. 49% of the compensation package, or $420K, was in salary.
Kirk Coleman, Chief Financial Officer, earned $469K in 2023, a 23% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 22, 2024.